✦ LIBER ✦

Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: A phase II trial

✍ Scribed by William Y. Kim; Young E. Whang; Raj S. Pruthi; Maria Q. Baggstrom; W. Kimryn Rathmell; Julian G. Rosenman; Eric M. Wallen; Lav K. Goyal; Gayle Grigson; Catharine Watkins; Paul A. Godley

Book ID: 116956654
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 155 KB
Volume: 29
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2009.09.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of neoadjuvant docetaxel

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

✍ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib

POD-01.06: Phase II trial of weekly doce

POD-01.06: Phase II trial of weekly docetaxel and complete androgen blockade prior to radical prostatectomy in high-risk localized prostate cancer patients

✍ F.J. Gómez Veiga; A. Sousa; A. Alcaraz; J. Areal; N. Hannaoui; L.A. Aparicio; B. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 82 KB

NEOADJUVANT CHEMOHORMONAL TAXANE-BASED T

NEOADJUVANT CHEMOHORMONAL TAXANE-BASED THERAPY BEFORE RADICAL PROSTATECTOMY (RRP) IN HIGH-RISK PROSTATE CANCER: 4.4 YEARS' FOLLOW-UP OF A PHASE II TRIAL

✍ T. Prayer-Galetti; P. Sperandio; M. Gardiman; V. De Marco; A. Cisternino; G. Bet 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Long-term follow-up of a neoadjuvant che

Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer

✍ Tomaso Prayer-Galetti; Emilio Sacco; Francesco Pagano; Marina Gardiman; Antonio 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Dose-volume impact in high-dose-rate Iri

Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer- a phase II study

✍ Michael Pinkawa; Karin Fischedick; Peter Treusacher; Branka Asadpour; Bernd Gage 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 85 KB